anu's laboratories

8/8/2019 Anu's Laboratories

http://slidepdf.com/reader/full/anus-laboratories 1/28

1ANU¶S LABORATORIES LTD. 10/2/2010

ANU·S LABORATORIES LTD.




INTRODUCTION

ISO 9001:2000 certified company established in 1996 by K.Haribabu, MD.

Manufacture of quality drug intermediates

2,4-Dichloro-5 Fluoro Acetophenone has enabled the brand to

establish itself as the flagship product of the organization.




FOUNDER

Mr. K. Haribabu is a Chartered Accountant and ranked 20th on an

All India merit basis in the year 1980.

Career

1981-1988, joined SOL as Accounts Officer and resigned asGeneral Manager (Finance)

1988-1996, was Vice-President (Finance) in Powmex Steels Ltd.

(now GKW).




PRODUCTS

Basic Intermediates

Advanced Intermediates.

Fine Chemicals




CORE COMPETENCIES

Research & Development

Complying with environmental norms

Quality Standards

Existing client relationship

Synergy of Business Lines

Experienced management team

Market Penetration




CORE COMPETENCIES ² R & D

Developing technologies for new products

Establishing processes in the laboratory for

products to be scaled up

Custom Synthesis

Contract Research

Process development for improving quality

and economies



Developing technologies that reduce and

minimize the generation of waste

40% of R&D directed for reducing or

eliminating waste

40% go for recovery of by-products, oreffluent treatment

Since its inception company has been

working on developing technologies which

lead to reduction in water consumption 9ANU¶S LABORATORIES LTD. 10/2/2010

CORE COMPETENCIES - COMPLYING WITH ENVIRONMENTAL NORMS




CORE COMPETENCIES - QUALITY STANDARD

The Company follows cGMP (Good Manufacturing Practices)

Quality Assurance

Quality Improvement Measures

Quality Systems Warehouse

Quality Systems ² QC & A

Quality Systems - Maintenance




ORGANIZATIONAL STAKEHOLDERS

INSIDE STAKEHOLDERS ² THE WORKFORCE





INSIDE STAKEHOLDER

S ² THE MANAGEMENT

Professionals with proven track records in the

commercial, chemical engineering and organic

chemistry fields.

Promoters hailing from different fields of expertise

Mix of requisite skill sets

Able to handle challenging inorganic growth opportunities





OUTSIDE STAKEHOLDERS - CUSTOMERS

Constantly tries to address customer needs

Production and research facilities helps to

Get repeat business from customers

Maintain a long term working relationship

Improve its customer retention strategy





OUTSIDE STAKEHOLDERS - OVERSEAS CUSTOMERS



Sreepathi Pharmaceuticals LtdSuven Life Sciences LtdRALLIS India Limited.


OUTSIDE STAKEHOLDERS - DOMESTIC CUSTOMERS

Matrix Laboratories Ltd.Dr. Reddy¶s LaboratoriesHETERO LabsSUN PharmaceuticalsNicholas Piramal India Ltd.Neuland LaboratoriesDivi's Laboratories LtdBallarpur Industries LimitedAurobindo Pharma LimitedHiran Orgochem LtdHikal LtdJubilant Organosys Ltd






OUTSIDE STAKEHOLDERS - DOMESTIC CUSTOMERS




ASSOCIATE COMP ANIES

Mr. K. Hari Babu, MD became the co-promoter of

Nitya Laboratories Limited in 2004 by making a

strategic investment in Nitya Laboratories Limited.




ORGANIZATIONAL STRUCTURE

Organic structure to promote innovation

Flat and allows a lot of decision making power to

lower levels of management.

Decen

tral

ized

Mutual adjustment allows research people to be

creative, innovative and to take risks.




OPERATIONAL HIERARCHY/CHAIN OF COMMAND



Organizational Ethics/Code of conduct

Very high Ethical and Moral Standards over the years Model Code of Conduct for Directors and Senior

Management personnel.

The Board of Directors of the Company adopted thisCode of Conduct and Ethics as a testimony of its

commitment to adhere to the standards of loyalty,honesty, integrity and the avoidance of conflicts of interest.

The code of conduct is reviewed by the Board fromtime to time





GROWTH OF THE ORGANIZATION




ACHIEVEMENTS

State Level Best SSI Entrepreneur Award for the year 2001-02 from the A.P.State Government.

Market Penetration Leadership in the Indian Pharmaceutical IntermediatesMarket by M/s Frost & Sullivan for the year 2005.

Consistent and long-term relationship with customers.

Developed ¶A Cleaner Production Process· by recovering by-products of

commercial value from waste water. Challenged the Chinese monopoly & attained leadership position in many

of its products.

ISO 9001 and Q9001-2000 Certifications.

Anu's R&D recognized by Dept. of Scientific and Industrial Research (DSIR),Govt. of India, New Delhi.




Major E vents1996-97

Incorporation

First Product manufactured -2 4 Dichloro 5 Fluoro Acetophenone (DCFA)

1998-99

Purchased Land,Building, Plant and Machinery

2001-02

Introduced another major drug intermediate viz. Chlorohexanone

Granted subsidy of Rs. 7.90 lakhs from Andhra Pradesh Pollution Control Board as incentive forimplementing projects for recovery of by-products and for showing our commitment towards "Cleaner

Production".2002-03

Certified ISO 9001-2000 from AQA International

2004-05

Introduced another drug intermediate Methyl-4(4-Chloro 1-Oxo butyl) and Di Methyl Phenyl Acetate

2006-07

Best Practices Award for Market penetration leadership from Frost and Sullivan for the year 2005.




FUTURE EXP ANSION

The company will be raising 250 cr Further Expansion

Acquisitions

Graduating to API

Going in forward in setting up a US FDA-compliant API manufacturing

facility in Vizag with an outlay of 63 cr, is expected to go on stream byOctober 2009.

There are five new intermediaries in Pipeline out of which a couple of

them are expected to be commercialized in the next two months.




Conclusion

The company has good growth prospects when compared to peers.

The established client-relationships provide some assurance on earnings.

The company does not enter into long-term contracts for the API business,

which it believes restricts ability to bargain for better prices.

Anu·s Labs has maintained superior operating margins at around 20-22

per cent for the last 20 months as its tie-up with Nitya Laboratories, a

promoter group company, has paid rich dividends.

The company focuses on being cost competetive.

It may also be able to increase presence in Contract Research and

Manufacturing Services (CR AMS) space and maintain a fair pace of growth

due to a dominant position in its portfolio of products.




Sources and References

Business Standard

Annual Report

Red Herring Prospectus

www.anulabs.com

www.expresspharmaonline.com www.moneycontrol.com

K Hari Babu, MD

N.S.Naidu, GM (HR)




THANK YOU

anu's laboratories

Documents